Turnstone Biologics Statistics

Total Valuation

TSBX has a market cap or net worth of $9.48 million. The enterprise value is -$34.08 million.

Market Cap	9.48M
Enterprise Value	-34.08M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TSBX has 23.13 million shares outstanding. The number of shares has increased by 99.23% in one year.

Current Share Class	23.13M
Shares Outstanding	23.13M
Shares Change (YoY)	+99.23%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	3.83%
Owned by Institutions (%)	28.71%
Float	13.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.22
P/TBV Ratio	0.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -99.55% and return on invested capital (ROIC) is -61.55%.

Return on Equity (ROE)	-99.55%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-61.55%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$885,463
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TSBX has paid $37,000 in taxes.

Income Tax	37,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-85.48%
50-Day Moving Average	0.41
200-Day Moving Average	0.96
Relative Strength Index (RSI)	53.70
Average Volume (20 Days)	126,888

Short Selling Information

The latest short interest is 447,632, so 1.94% of the outstanding shares have been sold short.

Short Interest	447,632
Short Previous Month	399,857
Short % of Shares Out	1.94%
Short % of Float	3.35%
Short Ratio (days to cover)	2.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-72.49M
Pretax Income	-75.09M
Net Income	-70.84M
EBITDA	-70.50M
EBIT	-72.49M
Earnings Per Share (EPS)	-$3.07

Full Income Statement

Balance Sheet

The company has $45.28 million in cash and $1.70 million in debt, giving a net cash position of $43.59 million or $1.88 per share.

Cash & Cash Equivalents	45.28M
Total Debt	1.70M
Net Cash	43.59M
Net Cash Per Share	$1.88
Equity (Book Value)	43.64M
Book Value Per Share	1.89
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-99.23%
Shareholder Yield	n/a
Earnings Yield	-745.20%
FCF Yield	n/a

Analyst Forecast

The average price target for TSBX is $4.75, which is 1,058.54% higher than the current price. The consensus rating is "Buy".

Price Target	$4.75
Price Target Difference	1,058.54%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	-4.90%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a